Oslo - 25. April 2016 - Serodus ASA (Oslo Axess, SER) will present the company and future strategy to investors and shareholders at Hotel Radisson Blu Royal, Hammerichs gade 1, København, on Monday 2 of May 2016 at 16:00. The presentation will be held by CEO Eva Steiness and the rest of the management group. Please notify participation by e-mail to tore.kvam@serodus.com.

For more information contact:

Tore Kvam

CFO, Serodus ASA

Mobile: +47 959 34 199

e-mail: tore.kvam@serodus.com

Serodus ASA is a Norwegian drug development company, focusing on new therapeutic products for the treatment of metabolic and cardiovascular diseases with large unmet clinical needs. The company's business model is to seek partnering with international pharmaceutical companies after having demonstrated clinical effect in humans. For more information see www.serodus.com.

Serodus ASA issued this content on 25 April 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 25 April 2016 11:54:06 UTC

Original Document: http://www.serodus.com/News/2016/Invitation-to-a-presentation-of-Serodus-in-Copenhagen